Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Kovai Medical Center and Hospital Limited (KOVAI.NS)
Coimbatore, IN
Kovai Medical Center and Hospital Limited, founded in 1985 and based in Coimbatore, India, provides a comprehensive suite of hospital and educational services. The company operates through two primary divisions: Healthcare Services and Education Services. Within its extensive healthcare segment, Kovai Medical Center manages numerous medical facilities that offer a wide array of specialized treatments. These include critical care, emergency medicine, dermatology, endocrinology and diabetology, fertility and reproductive medicine, gastroenterology and hepatology, hematology, internal medicine, a dedicated Heart Institute, neonatology, nephrology, neurology, obstetrics and gynecology, pediatric surgery, pulmonology, psychological medicine, and rheumatology, alongside general health check programs. The surgical division provides a broad spectrum of procedures, encompassing general, gastrointestinal, bariatric, laparoscopic, cardio-thoracic, orthopedic and joint replacement, neuro, plastic, reconstructive, cosmetic, urology, spine, ENT/head and neck, dentistry/facio maxillary, and vascular surgeries. Supporting these medical and surgical services are advanced interventional radiology and imaging sciences, nuclear medicine and PET CT, laboratory medicine facilities, and physical medicine and rehabilitation centers. The company further operates dedicated cancer and ayurvedic wellness centers, in addition to critical emergency and trauma services and organ transplant programs. Beyond healthcare provision, Kovai Medical Center and Hospital Limited also contributes to medical education by operating a medical college located in Coimbatore.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.80% | -1.81% | -5.46% | -2.50% | -2.50% | -2.50% | -2.50% | +146.18% | +235.97% | +235.97% | +5,229.18% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Medical - Care Facilities: +10.2%+15.7% ★ Q1'26: +15.9% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+17.0% Q1'26: +9.1% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+13.6% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+20.8% ★ Q1'26: +19.8% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+18.0% ★ Q1'26: +16.9% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×0.92× ★ Q1'26: 0.91× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-25 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Nalla G. Palaniswami | Chairman & MD | 72M | — |
| Thavamani Devi Palaniswami | Vice Chairman & Joint MD | 70M | — |
| Arun N. Palaniswami MBBS MDAB | Executive Director | 40M | — |
| K. Gopikrishnan | Chief Financial Officer | 10M | male |
| C. Tamilselvan | Vice President of Materials | — | male |
| J. Sivakumaran | Chief Operating Officer | — | — |
| S. Anto Vaz | Chief Medical Physicist & Radiological Safety Officer | — | male |
| S. Karthikeyan | Chief Executive Officer of Institute of Health Science & Research | — | male |
| Rajendran Ponmanikandan | Company Secretary & Compliance Officer | — | male |
| M.G Sridhar | Vice Principal & Professor of Biochemistry - IHSR | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for KOVAI.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
